Role of the toll-like receptor 4 polymorphism Asp299Gly in longevity and myocardial infarction in German men

Mechanisms of Ageing and Development

Volumn 128, Issue 5-6, 2007, Pages 409-411

  Nebel, Almut ^a   Flachsbart, Friederike ^a   Schäfer, Arne ^a   Nothnagel, Michael ^b   Nikolaus, Susanna ^b   Mokhtari, Nour Eddine El ^b   Schreiber, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Case control association; Longevity; Mycocardial infarction; Replication; Reporting bias; Reproducibility; Toll like receptor 4 gene

Indexed keywords

TOLL LIKE RECEPTOR 4;

AGED; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; AMINO ACID SUBSTITUTION; ASPARTIC ACID; GERMANY; GLYCINE; HUMANS; LONGEVITY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 4;

EID: 34347375715     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2007.04.001     Document Type: Article

References (14)

1. Ameziane N., Beillat T., Verpillat P., Chollet-Martin S., Aumont M.C., Seknadji P., Lamotte M., Lebret D., Ollivier V., and de Prost D. Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler. Thromb. Vasc. Biol. 23 (2003) e61-e64
2. Balistreri C.R., Candore G., Colonna-Romano G., Lio D., Caruso M., Hoffmann E., Franceschi C., and Caruso C. Role of toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292 (2004) 2339-2340
3. Edfeldt K., Bennet A.M., Eriksson P., Frostegard J., Wiman B., Hamsten A., Hansson G.K., de Faire U., and Yan Z.Q. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 25 (2004) 1447-1453
4. Edfeldt K., Swedenborg J., Hansson G.K., and Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 (2002) 1158-1161
5. El Mokhtari N.E., Ott S.J., Nebel A., Simon R., and Schreiber S. A functional variant in the CARD4 gene and risk of premature coronary heart disease. Int. J. Immunogenet. 33 (2006) 307-311
6. Ioannidis J.P.A. Journals should publish all "null" results and should sparingly publish "positive" results. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 186
7. Ioannidis J.P.A. Molecular bias. Eur. J. Epidemiol. 20 (2005) 739-745
8. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., Willeit J., and Schwartz D.A. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347 (2002) 185-192
9. Koch W., Hoppmann P., Pfeufer A., Schomig A., and Kastrati A. Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. Eur. Heart J. 27 (2006) 2524-2529
10. Krawczak M., Nikolaus S., von Eberstein H., Croucher P.J., El Mokhtari N.E., and Schreiber S. PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet. 9 (2006) 55-61
11. Morange P.E., Tiret L., Saut N., Luc G., Arveiler D., Ferrieres J., Amouyel P., Evans A., Ducimetiere P., Cambien F., and Juhan-Vague I. LR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Eur. J. Hum. Genet. 12 (2004) 1041-1049
12. Nebel A., Croucher P.J., Stiegeler R., Nikolaus S., Krawczak M., and Schreiber S. No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 7906-7909
13. R Development Core Team, 2006. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org.
14. Zee R.Y., Hegener H.H., Gould J., and Ridker P.M. Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis. Stroke 36 (2005) 154-157